Search for: "Bristol Associates, Inc., in the Matter of" Results 41 - 55 of 55
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jun 2010, 9:54 am by smtaber
In a recent enforcement action, EPA alleged that Michael Perugini violated the federal Lead Disclosure Rule when he failed to disclose information about lead paint to seven tenants when leasing units at his Bristol apartment buildings. [read post]
11 May 2010, 4:53 am by Jeffrey Vicq
The Board seemingly took another troubling step in this direction in a subsequent decision— FreemantleMedia North America Inc. v Wright Alternative Advertising Inc. (2009 77 C.P.R. (4th) 311). [read post]
27 Apr 2010, 5:01 am by Broc Romanek
" The Australian Shareholders Association (ASA) said that the response was "much stronger than they had anticipated. [read post]
1 Apr 2010, 3:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: US: District Court S D New York: ‘Isolated DNA’ patents fail to claim patentable subject matter: Association for Molecular Pathology and ACLU v. [read post]
13 Dec 2009, 8:58 pm by smtaber
— Seth Borenstein, The Associated Press, December 6, 2009 With the world losing the battle against global warming so far, experts are warning that humans need to follow nature’s example: Adapt or die. [read post]
17 Aug 2009, 10:44 am
(Malden, MA; Same Above, President) Banyakitara Association Inc. [read post]
19 Sep 2008, 6:00 pm
: (IPRoo), Giving Goliath the slingshot: Review of the National Innovation System on 'the costs of enforcing IP rights': (Australia & New Zealand Intellectual Property Law), Take patent policy away from lawyers, says Australian government report: (IAM), Advisory Council announces review of scope of patentable subject matter: (International Law Office), Federal Court's flu shot for patent law: Notice to Practitioners - Proceedings under the Patents Act 1990 (Cth):… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]
27 Apr 2007, 12:04 pm
Issa suggested that perhaps "one window" might be provided for a post-grant proceeding, one shot at a patent, no matter when that window would be. [read post]
1 Feb 2007, 6:07 am
Bristol-Myers Squibb, 1998 WL 812318, *28 n.248 (M.D. [read post]
26 Jan 2007, 6:09 am
In August 2006, generic drug maker Apotex Inc. began selling a cheaper version of Plavix, a blood thinner Bristol-Myers co-markets with Sanofi-Aventis SA, after an agreement to settle a patent dispute fell apart. [read post]